Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Biochemistry (Mosc) ; 89(3): 507-522, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38648769

RESUMEN

Some tricyclic antidepressants (TCAs), including amitriptyline (ATL), clomipramine (CLO), and desipramine (DES), are known to be effective for management of neuropathic pain. It was previously determined that ATL, CLO, and DES are capable of voltage-dependent blocking of NMDA receptors of glutamate (NMDAR), which play a key role in pathogenesis of neuropathic pain. Despite the similar structure of ATL, CLO, and DES, efficacy of their interaction with NMDAR varies significantly. In the study presented here, we applied molecular modeling methods to investigate the mechanism of binding of ATL, CLO, and DES to NMDAR and to identify structural features of the drugs that determine their inhibitory activity against NMDAR. Molecular docking of the studied TCAs into the NMDAR channel was performed. Conformational behavior of the obtained complexes in the lipid bilayer was simulated by the method of molecular dynamics (MD). A single binding site (upper) for the tertiary amines ATL and CLO and two binding sites (upper and lower) for the secondary amine DES were identified inside the NMDAR channel. The upper and lower binding sites are located along the channel axis at different distances from the extracellular side of the plasma membrane. MD simulation revealed that the position of DES in the lower site is stabilized only in the presence of sodium cation inside the NMDAR channel. DES binds more strongly to NMDAR compared to ATL and CLO due to simultaneous interaction of two hydrogen atoms of its cationic group with the asparagine residues of the ion pore of the receptor. This feature may be responsible for the stronger side effects of DES. It has been hypothesized that ATL binds to NMDAR less efficiently compared to DES and CLO due to its lower conformational mobility. The identified features of the structure- and cation-dependent mechanism of interaction between TCAs and NMDAR will help in the further development of effective and safe analgesic therapy.


Asunto(s)
Antidepresivos Tricíclicos , Simulación del Acoplamiento Molecular , Simulación de Dinámica Molecular , Receptores de N-Metil-D-Aspartato , Receptores de N-Metil-D-Aspartato/metabolismo , Receptores de N-Metil-D-Aspartato/química , Antidepresivos Tricíclicos/farmacología , Antidepresivos Tricíclicos/metabolismo , Antidepresivos Tricíclicos/química , Sitios de Unión , Amitriptilina/química , Amitriptilina/metabolismo , Amitriptilina/farmacología , Humanos , Clomipramina/farmacología , Clomipramina/química , Clomipramina/metabolismo , Cationes/metabolismo , Cationes/química , Desipramina/farmacología , Unión Proteica
2.
Biomark Med ; 14(12): 1069-1084, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32969243

RESUMEN

Aim: To explore the mechanism of gastric carcinogenesis by mining potential hub genes and to search for promising small-molecular compounds for gastric cancer (GC). Materials & methods: The microarray datasets were downloaded from Gene Expression Omnibus database and the genes and compounds were analyzed by bioinformatics-related tools and software. Results: Six hub genes (MKI67, PLK1, COL1A1, TPX2, COL1A2 and SPP1) related to the prognosis of GC were confirmed to be upregulated in GC and their high expression was correlated with poor overall survival rate in GC patients. In addition, eight candidate compounds with potential anti-GC activity were identified, among which resveratrol was closely correlated with six hub genes. Conclusion: Six hub genes identified in the present study may contribute to a more comprehensive understanding of the mechanism of gastric carcinogenesis and the predicted potential of resveratrol may provide valuable clues for the future development of targeted anti-GC inhibitors.


Asunto(s)
Perfilación de la Expresión Génica , Genes Relacionados con las Neoplasias , Proteínas de Neoplasias/genética , Bibliotecas de Moléculas Pequeñas/química , Bibliotecas de Moléculas Pequeñas/farmacología , Neoplasias Gástricas/tratamiento farmacológico , Neoplasias Gástricas/genética , Amiodarona/química , Proteínas de Ciclo Celular/genética , Clomipramina/química , Colágeno Tipo I/genética , Bases de Datos Genéticas , Conjuntos de Datos como Asunto , Regulación Neoplásica de la Expresión Génica , Humanos , Antígeno Ki-67/genética , Levalorfano/química , Proteínas Asociadas a Microtúbulos/genética , Osteopontina/genética , Piroxicam/química , Procaína/química , Procaína/farmacología , Procaína/uso terapéutico , Proteínas Serina-Treonina Quinasas/genética , Proteínas Proto-Oncogénicas/genética , Resveratrol/química , Resveratrol/farmacología , Bibliotecas de Moléculas Pequeñas/uso terapéutico , Ácido Ursodesoxicólico/química , Vorinostat/química , Quinasa Tipo Polo 1
3.
Eur J Med Chem ; 187: 111915, 2020 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-31838329

RESUMEN

A series of 10,11-dihydro-5H-dibenzo [b,f]azepine hydroxamates (4-15) were synthesized, behaving as histone deacetylase inhibitors, and examined for their influence on vascular cognitive impairment (VCI), which correlated with dementia. The results revealed that (E)-3-(4-(((3-(3-chloro-10,11-dihydro-5H-dibenzo [b,f]azepin-5-yl)propyl)amino)methyl)phenyl)-N-hydroxy-acrylamide (13) increases cerebral blood flow (CBF), attenuates cognitive impairment, and improves hippocampal atrophy in in vivo study. It is also able to increase the level of histone acetylation (H3K14 or H4K5) in the cortex and hippocampus of chronic cerebral hypoperfusion (CCH) mice; as a result, it could be a potential HDAC inhibitor for the treatment of vascular cognitive impairment.


Asunto(s)
Azepinas/farmacología , Clomipramina/análogos & derivados , Disfunción Cognitiva/tratamiento farmacológico , Demencia Vascular/tratamiento farmacológico , Inhibidores de Histona Desacetilasas/farmacología , Histona Desacetilasas/metabolismo , Ácidos Hidroxámicos/farmacología , Sustancias Protectoras/farmacología , Animales , Azepinas/química , Línea Celular Tumoral , Clomipramina/química , Clomipramina/farmacología , Disfunción Cognitiva/metabolismo , Demencia Vascular/metabolismo , Relación Dosis-Respuesta a Droga , Inhibidores de Histona Desacetilasas/síntesis química , Inhibidores de Histona Desacetilasas/química , Humanos , Ácidos Hidroxámicos/síntesis química , Ácidos Hidroxámicos/química , Masculino , Ratones , Ratones Endogámicos C57BL , Estructura Molecular , Sustancias Protectoras/síntesis química , Sustancias Protectoras/química , Relación Estructura-Actividad
4.
Nanomedicine (Lond) ; 13(17): 2139-2154, 2018 09.
Artículo en Inglés | MEDLINE | ID: mdl-30129397

RESUMEN

AIM: Pharmacologic agents that affect autophagy were tested for their abilities to enhance macrophage nanoformulated antiretroviral drug (ARV) depots and its slow release. METHODS: These agents included URMC-099, rapamycin, metformin, desmethylclomipramine, 2-hydroxy-ß-cyclodextrin (HBC) and clonidine. Each was administered with nanoformulated atazanavir (ATV) nanoparticles to human monocyte-derived macrophages. ARV retention, antiretroviral activity and nanocrystal autophagosomal formation were evaluated. RESULTS: URMC-099, HBC and clonidine retained ATV. HBC, URMC-099 and rapamycin improved intracellular ATV retention. URMC-099 proved superior among the group in affecting antiretroviral activities. CONCLUSION: Autophagy inducing agents, notably URMC-099, facilitate nanoformulated ARV depots and lead to sustained release and improved antiretroviral responses. As such, they may be considered for development as part of long acting antiretroviral treatment regimens.


Asunto(s)
Fármacos Anti-VIH/química , Sulfato de Atazanavir/farmacología , Autofagia/efectos de los fármacos , Portadores de Fármacos/química , Nanopartículas/química , Fármacos Anti-VIH/administración & dosificación , Fármacos Anti-VIH/farmacología , Sulfato de Atazanavir/administración & dosificación , Sulfato de Atazanavir/química , Supervivencia Celular/efectos de los fármacos , Clomipramina/administración & dosificación , Clomipramina/análogos & derivados , Clomipramina/química , Clomipramina/farmacología , Clonidina/administración & dosificación , Clonidina/química , Clonidina/farmacología , Interacciones Farmacológicas , Liberación de Fármacos , VIH-1/efectos de los fármacos , Humanos , Macrófagos/citología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Metformina/administración & dosificación , Metformina/química , Metformina/farmacología , Tamaño de la Partícula , Piridinas/administración & dosificación , Piridinas/química , Piridinas/farmacología , Pirroles/administración & dosificación , Pirroles/química , Pirroles/farmacología , Sirolimus/administración & dosificación , Sirolimus/química , Sirolimus/farmacología , Distribución Tisular , beta-Ciclodextrinas/administración & dosificación , beta-Ciclodextrinas/química , beta-Ciclodextrinas/farmacología
5.
Artículo en Inglés | MEDLINE | ID: mdl-28825989

RESUMEN

The applicability of Amino-functionalized Fe3O4 nanoparticles (NPs) as an effective adsorbent was developed for the extraction and determination of clomipramine (CLP) in plasma sample by ultrasound-assisted dispersive magnetic solid phase extraction (UADM-SPE) and high-performance liquid chromatography-ultraviolet (HPLC-UV) detection. Fabrication of the Fe3O4@SiO2-NH2 magnetic nanoparticles confirmed by Fourier transform infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA), scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The effect of different extraction parameters (i.e. pH of the sample solution, the amount of magnetic nanoparticles (MNPs), sample volume, temperature and sonication time) on the extraction recovery of CLP were investigated by response surface methodology through central composite design (CCD). The optimum condition is obtained when the affecting parameters are set to: pH of the sample solution=9, the amount of MNPs=37mg, sample volume=23mL, 25°C temperature and sonication time=1min. Under the optimum condition, extraction recovery was 90.6% with relative standard deviation of 3.5%, and enrichment factor of 117. The linear range for determination of CLP was 0.017-0.70mgL-1 with a determination coefficient (R2) of 0.999. Limit of detection (LOD) and limit of quantification (LOQ) were 0.005 and 0.0167mgL-1, respectively. The established UADM-SPE-HPLC-UV method was rapid, simple and efficient for determination of CLP in human plasma samples.


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Clomipramina/sangre , Nanopartículas de Magnetita/química , Extracción en Fase Sólida/métodos , Sonicación/métodos , Clomipramina/química , Clomipramina/aislamiento & purificación , Humanos , Límite de Detección , Modelos Lineales , Reproducibilidad de los Resultados , Proyectos de Investigación
6.
Bioorg Med Chem ; 23(5): 996-1010, 2015 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-25661449

RESUMEN

Trypanothione reductase (TR) is an enzyme critical to the maintenance of the thiol redox balance in trypanosomatids, including the genera Trypanosoma and Leishmania that are parasites responsible for several serious diseases. Analogs of clomipramine were prepared since clomipramine is reported to inhibit TR and cure mice infected with trypanosomes, however its psychotropic activity precludes its use as an anti-trypanosomal therapeutic. The clomipramine analogs contained a tricyclic dibenzosuberyl moiety. Additionally a series of polyamines with N-dibenzosuberyl substituents were prepared. All compounds studied were competitive inhibitors of TR and showed trypanocidal activities against Trypanosoma brucei in vitro. The analogs of clomipramine were poor inhibitors of TR, whereas the polyamine derivatives were effective TR inhibitors with the most potent compound, N(4),N(8)-bis(dibenzosuberyl)spermine (7), having a Ki value of 0.26µM. However, compound (7) did not prolong the lives of mice infected with trypanosomes. Analysis of docking studies indicated: the tricyclic groups of inhibitors bind at four distinct hydrophobic regions in the active site of TR; the importance of the chlorine substituent of clomipramine in binding to TR; and binding of the dibenzosuberyl groups of (7) occur at separate and distinct hydrophobic regions within the active site of TR.


Asunto(s)
Clomipramina/análogos & derivados , Inhibidores Enzimáticos/farmacología , NADH NADPH Oxidorreductasas/antagonistas & inhibidores , Poliaminas/farmacología , Tripanocidas/farmacología , Animales , Clomipramina/química , Inhibidores Enzimáticos/química , Ratones , Simulación del Acoplamiento Molecular , Poliaminas/química , Trypanosoma brucei brucei/efectos de los fármacos , Trypanosoma brucei brucei/enzimología
7.
Cell Death Dis ; 5: e1203, 2014 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-24787015

RESUMEN

Inhibition of distinct ubiquitin E3 ligases might represent a powerful therapeutic tool. ITCH is a HECT domain-containing E3 ligase that promotes the ubiquitylation and degradation of several proteins, including p73, p63, c-Jun, JunB, Notch and c-FLIP, thus affecting cell fate. Accordingly, ITCH depletion potentiates the effect of chemotherapeutic drugs, revealing ITCH as a potential pharmacological target in cancer therapy. Using high throughput screening of ITCH auto-ubiquitylation, we identified several putative ITCH inhibitors, one of which is clomipramine--a clinically useful antidepressant drug. Previously, we have shown that clomipramine inhibits autophagy by blocking autophagolysosomal fluxes and thus could potentiate chemotherapy in vitro. Here, we found that clomipramine specifically blocks ITCH auto-ubiquitylation, as well as p73 ubiquitylation. By screening structural homologs of clomipramine, we identified several ITCH inhibitors and putative molecular moieties that are essential for ITCH inhibition. Treating a panel of breast, prostate and bladder cancer cell lines with clomipramine, or its homologs, we found that they reduce cancer cell growth, and synergize with gemcitabine or mitomycin in killing cancer cells by blocking autophagy. We also discuss a potential mechanism of inhibition. Together, our study (i) demonstrates the feasibility of using high throughput screening to identify E3 ligase inhibitors and (ii) provides insight into how clomipramine and its structural homologs might interfere with ITCH and other HECT E3 ligase catalytic activity in (iii) potentiating chemotherapy by regulating autophagic fluxes. These results may have direct clinical applications.


Asunto(s)
Antidepresivos/farmacología , Autofagia/efectos de los fármacos , Inhibidores Enzimáticos/análisis , Inhibidores Enzimáticos/farmacología , Ensayos Analíticos de Alto Rendimiento/métodos , Ubiquitina-Proteína Ligasas/antagonistas & inhibidores , Sitios de Unión , Línea Celular Tumoral , Clomipramina/análogos & derivados , Clomipramina/química , Clomipramina/farmacología , Sinergismo Farmacológico , Humanos , Modelos Moleculares , Estructura Terciaria de Proteína , Reproducibilidad de los Resultados , Ubiquitina/metabolismo , Ubiquitina-Proteína Ligasas/química , Ubiquitina-Proteína Ligasas/metabolismo
8.
J Fluoresc ; 23(3): 533-42, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23456417

RESUMEN

Amitriptyline.HCl (AMI) and clomipramine.HCl (CMI) react with eosin Y (EY) in pH 3.8 NaAc-AcH buffer solution to form ion association complex which results in quenching of fluorescence of EY and appearance of a new resonance Rayleigh scattering (RSS) spectrum at 620 nm. The spectral characteristics of absorption, fluorescence and RSS spectra have been investigated. The factors influencing the reaction were studied and optimum conditions for the reaction have been determined. Based on fluorescence quenching, a simple and sensitive spectrofluorimetric method for determination of AMI and CMI has been developed. The fluorescence quenching intensity was measured at 550 nm using an excitation wavelength of 310 nm. The calibration graph was found to be rectilinear in the range 0.08-2.0 µg mL(-1) with detection limit of 0.017 µg mL(-1) for AMI and 0.06-2.0 µg mL(-1) with detection limit of 0.015 µg mL(-1) for CMI. The method can be satisfactorily applied to the determination of AMI and CMI in tablets without interference from commonly occurring exicipients. The recovery and RSD values obtained indicate good accuracy and precision of the method. The mechanism of the reaction and fluorescence quenching has also been discussed.


Asunto(s)
Amitriptilina/análisis , Amitriptilina/química , Clomipramina/análisis , Clomipramina/química , Eosina Amarillenta-(YS)/química , Colorantes Fluorescentes/química , Absorción , Tampones (Química) , Calibración , Composición de Medicamentos , Concentración de Iones de Hidrógeno , Indicadores y Reactivos/química , Cinética , Concentración Osmolar , Espectrometría de Fluorescencia , Temperatura
9.
Crit Rev Eukaryot Gene Expr ; 22(3): 197-203, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23140161

RESUMEN

Langmuir-Blodgett (LB) technology was used to build a high-sensitivity enzyme-based biosensor for medical purposes. Recombinant fungal laccase from Rigidoporous lignosus, as previously described, was used to catalyze a widely used antidepressant in a micromolar range, namely, clomipramine. The topological properties of the laccase thin film were characterized via LB π-A isotherm and AFM (mean roughness 8.22 nm, compressibility coefficient 37.5 m/N). The sensitivity of the biosensor was investigated via UV spectroscopy, and linearity was found in the absorbance peak shift at 400 nm at drug concentration varying up to 20 uM. The enzyme kinetics was subsequently investigated with potentiometric and amperometric measurements, and we found electronic transfer of at least 1 electron, k(s) 0.57 s(-1), diffusion coefficient 3 × 10(-6) cm(2)/s, K(cat) 6825.92 min(-1), K(M) 4.1 uM, K(cat)/K(M) 2.8 × 10(7) mol(-1) s(-1), sensitivity of 440 nA/uM, maximum velocity 1706.48 nA/s, and response time less than 5 s. The amperometric and potentiometric measurements were repeated after a month, confirming the stability of the biosensor.


Asunto(s)
Técnicas Biosensibles/métodos , Lacasa/química , Clomipramina/sangre , Clomipramina/química , Electrodos , Humanos , Cinética , Lacasa/genética , Microscopía de Fuerza Atómica/métodos , Potenciometría/instrumentación , Proteínas Recombinantes/química
10.
J Mol Graph Model ; 38: 1-12, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23079638

RESUMEN

The dopamine transporter (DAT) facilitates the regulation of synaptic neurotransmitter levels. As a target for therapeutic and illicit psycho-stimulant drugs like antidepressants and cocaine, DAT has been studied intensively. Despite a wealth of mutational and physiological data regarding DAT, the structure remains unsolved and details of the transport mechanism, binding sites and conformational changes remain debated. A bacterial homolog of DAT, the leucine transporter (LeuT(Aa)) has been used as a template and framework for modeling and understanding DAT. Free energy profiles obtained from Multi-Configuration Thermodynamic Integration simulations allowed us to correctly identify the primary and secondary binding pockets of LeuT(Aa). A comparison of free energy profiles for dopamine and cocaine in DAT suggests that the binding site of cocaine is located in a secondary pocket, not the primary substrate site. Two recurring primary pathways for intracellular substrate release from the primary pocket are identified in both transporters using the Random Acceleration Molecular Dynamics method. One pathway appears to follow transmembranes (TMs) 1a and 6b while the other pathway follows along TMs 6b and 8. Interestingly, we observe that a single sodium ion is co-transported with leucine during both simulation types.


Asunto(s)
Proteínas Bacterianas/química , Proteínas Portadoras/química , Cocaína/química , Proteínas de Transporte de Dopamina a través de la Membrana Plasmática/química , Dopamina/química , Leucina/química , Secuencia de Aminoácidos , Animales , Sitios de Unión , Transporte Biológico , Clomipramina/química , Cocaína/metabolismo , Cristalografía por Rayos X , Dopamina/metabolismo , Cinética , Simulación del Acoplamiento Molecular , Datos de Secuencia Molecular , Unión Proteica , Estructura Terciaria de Proteína , Ratas , Alineación de Secuencia , Sodio/química , Sodio/metabolismo , Homología Estructural de Proteína , Especificidad por Sustrato , Termodinámica
11.
Bioorg Med Chem ; 20(1): 340-5, 2012 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-22115837

RESUMEN

Tricyclic antidepressants (TCAs), along with phenothyazines and some industrial chemicals, are shown to react with enzymes that exhibit peroxidase activity. These reactions result in the formation of reactive intermediates having unpaired electrons. The peroxidase oxidation and reactivity of two TCAs, desipramine and clomipramine, were investigated. As a model of peroxidase, horseradish peroxidase (HRP) was employed. The products of the peroxidase catalyzed oxidation of desipramine and clomipramine were identified as N-dealkylated compounds iminodibenzyl and 3-chloroiminodibenzyl using the GC/MS technique. Both drugs formed broad UV/vis absorption spectra in the presence of HRP and H(2)O(2), indicating the formation of a radical cations-reactive intermediate of the oxidation reaction. The dynamics of the formation of the desipramine intermediate was studied using UV/vis spectroscopy. The extinction coefficient was measured for the reactive intermediate, 7.80×10(3)M(-1)cm(-1), as well as the apparent Michaelis-Menten and catalytic constants, 4.4mM and 2.3s(-1), respectively. Both desipramine and clomipramine degraded DNA in the presence of HRP/H(2)O(2), as was revealed by agarose gel electrophoresis and PCI extraction. Manipulating the kinetic parameters of drug's radical formation and determining the extent of degradation to biomolecules could be potentially used for designing effective agents exhibiting specific reactivity.


Asunto(s)
Antidepresivos/metabolismo , Clomipramina/metabolismo , ADN/metabolismo , Desipramina/metabolismo , Antidepresivos/química , Biocatálisis , Clomipramina/química , ADN/química , Desipramina/química , Peroxidasa de Rábano Silvestre/metabolismo , Peróxido de Hidrógeno/metabolismo , Cinética , Oxidación-Reducción
12.
J Colloid Interface Sci ; 361(1): 42-8, 2011 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-21679963

RESUMEN

The clouding behavior, i.e., formation of phase separation at elevated temperature (the temperature being known as cloud point (CP)), of three amphiphilic drugs, amitriptyline (AMT), clomipramine (CLP) and imipramine (IMP) hydrochlorides in the presence of various additives, like cationic surfactants (conventional and gemini), nonionic surfactants, bile salts, anionic hydrotropes, sodium salts of fatty acids and cyclodextrin has been investigated. These additives are generally used as drug delivery systems. The drugs used are tricyclic antidepressants. All the surfactants increase the CP of mixed micelles formed by cationic (conventional and gemini) and nonionic surfactants. Hydrotropes, bile salts and fatty acid salts, when added in low concentrations, increase the CP, whereas at high concentrations, they decrease it. ß-Cyclodextrin behaves as simple sugar and decreases the CP of the drug solutions.


Asunto(s)
Amitriptilina/química , Antidepresivos Tricíclicos/química , Clomipramina/química , Excipientes/química , Imipramina/química , Ácidos y Sales Biliares/química , Ciclodextrinas/química , Ácidos Grasos/química , Transición de Fase , Sales (Química)/química , Tensoactivos/química , Temperatura
13.
J Liposome Res ; 21(3): 194-202, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20624028

RESUMEN

The effects of tricylic antidepressant clomipramine (CLO) on the membrane properties of saturated dimyristoyl phosphatidylcholine and dipalmitoyl phosphatidylcholine as well as on unsaturated egg yolk phosphatidylcholine liposomes were investigated by the electron paramagnetic resonance spin-labeling technique, in combination with the simulation of the spectra, taking into account that the membrane is heterogeneous and composed of the regions with different fluidity characteristics. Different spin labels, monitoring membrane properties in the upper and inner parts of the membrane, were used. In general, two spectral components, having different motional characteristics, were detected in all liposomes investigated. In liposomes with saturated chains, CLO decreased the phase-transition temperature, disordered the membrane, and increased polarity in the upper part of the membrane. However, less impact was observed in liposomes with unsaturated chains. In dipalmitoyl phosphatidylcholine liposomes, it also induced molecular rearrangements near the pretransition temperature. The presence of 30 mol% cholesterol increased the fluidizing effect of CLO and modified the lateral diffusion of nitroxide in the inner part of the membrane. A unique anomalous increase in diffusion of nitroxide, dependent on CLO concentration, was detected in the temperature region where the phosphatidylcholine membrane without cholesterol experiences the phase transitions. Since the changes in the central part of the membrane were even more pronounced than in the upper part of the membrane, it could be concluded that CLO incorporates into the membrane with its hydrophobic ring parallel to the phospholipid chains.


Asunto(s)
Colesterol/química , Clomipramina/química , Espectroscopía de Resonancia por Spin del Electrón/métodos , Membrana Dobles de Lípidos/química , Liposomas/química , Fosfatidilcolinas/química , Antidepresivos Tricíclicos/química , Simulación por Computador , Estructura Molecular
14.
Colloids Surf B Biointerfaces ; 81(1): 152-7, 2010 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-20674295

RESUMEN

Clomipramine hydrochloride (CLP) is an antidepressant drug which shows temperature dependent phase separation, also known as the cloud point (CP). Increase in pH decreases the CP of the drug solution. Addition of ureas/thioureas at a fixed pH (6.25) decreases/increases the CP. In ureas, presence of >CO bond causes a decrease in repulsions among positively charged drug molecules. However, >CS bond (of thioureas) behaves oppositely and hence CP increases. Cationic and non-ionic surfactants form mixed micelles and hence increase the CP. Anionic surfactants, at low concentrations, retard micellization and increase the CP. At higher concentrations, these surfactants also form mixed micelles and, due to charge opposite to the drug molecules, reduce the repulsion among micelles and act as CP suppressors. Increase in solution pH/drug concentration at different fixed concentrations of CTAB causes the CP to decrease/increase. Dye solubilization results with the drug have provided proof to the above explanation.


Asunto(s)
Clomipramina/química , Tensoactivos/química , Urea/química , Antidepresivos Tricíclicos/química , Compuestos Azo/química , Relación Dosis-Respuesta a Droga , Concentración de Iones de Hidrógeno , Estructura Molecular , Solubilidad , Espectrofotometría , Tensoactivos/farmacología , Tiourea/química , Tiourea/farmacología , Temperatura de Transición/efectos de los fármacos , Urea/farmacología
15.
Colloids Surf B Biointerfaces ; 64(1): 65-9, 2008 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-18291629

RESUMEN

Conductivity measurements have been carried out on aqueous solutions of two antidepressant drugs (nortriptyline hydrochloride and clomipramine hydrochloride) with four cationic surfactants (monomeric: cetyltrimethylammonium bromide, tetradecylammonium bromide; dimeric: 1,5-pentanediyl-alpha-omega-bis(hexadecyldimethylammonium bromide), 1,4-butanediyl-alpha,omega-bis(hexadecyldimethylammonium bromide) as well as with sodium chloride. Counterions from NaCl adsorb to the charged headgroup of the drug molecules and reduce the repulsion, hence cmc decreases. cmc values decreased with the addition of surfactants indicating mixed micelle formation. Experimental mole fraction of surfactants in micelle (X1) and their ideal values (X1 id) also support this explanation. Interaction parameter, beta, and excess free energy of micellization are negative suggesting synergism in mixed state. Activity coefficients are less than unity which means non-ideal mixing.


Asunto(s)
Antidepresivos Tricíclicos/química , Clomipramina/química , Conductividad Eléctrica , Micelas , Nortriptilina/química , Tensoactivos/química , Agua , Soluciones Farmacéuticas
16.
J Phys Chem B ; 112(1): 168-78, 2008 Jan 10.
Artículo en Inglés | MEDLINE | ID: mdl-18085762

RESUMEN

Imipramine (IPA) and its derivatives are used widely for the treatment of depression and other mental disorders. Although there are more than 20 FDA-approved antidepressant drugs, the search continues for better compounds with fewer deleterious side effects and higher efficacy. Over the past decade, several classes of antipsychotic drugs have been developed, which-in spite of their structural diversity-share an ability to modulate neurotransmission and to produce undesirable side effects. Phototoxicity is one of the most important side effects noted in treatment with tricyclic antidepressants (TCAs), but its mechanism has not yet been elucidated. To develop new knowledge regarding the relationship between the structure and the photophysics of these TCAs, we measured the photophysical properties of IPA, desimipramine (DIPA), and clomipramine (CIPA) in different solvents. The electronic configurations for the ground and the first excited singlet states were calculated using the AM1/RHF/CI and the AM1/RHF/HE semiempirical quantum theoretical methods, respectively. The ground-state properties are solvent-independent, while the emission maxima are red-shifted with increasing solvent polarity/polarizability. However, the fluorescence quantum yield is relatively low in all of the tested solvents (phif<0.02). The primary transient intermediates produced by 266 nm high-intensity laser photolysis are the solvated electron and the corresponding radical cation, with a negligible contribution of triplet-triplet absorption. The properties determined for the primary transients generated with a 266 nm laser flash are consistent with the photodamaging effects generated through a limited radical mechanism.


Asunto(s)
Clomipramina/química , Imipramina/análogos & derivados , Imipramina/química , Modelos Químicos , Iones/química , Estructura Molecular , Fotoquímica , Solventes , Espectrometría de Fluorescencia , Termodinámica , Factores de Tiempo
17.
Bioorg Med Chem ; 15(24): 7765-72, 2007 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-17870537

RESUMEN

A variety of tropane derivatives 14a-g were prepared via the reaction of the alcohol analogs 12a and 12b with substituted fluorobenzenes 13a-f. The prepared compounds were tested for their activity and selectivity toward the norepinephrine transporter (NET) and serotonin transporter (SERT) using yohimbine-induced mortality and 5-hydroxytryptophan-induced neurotoxicity in mice, respectively. All the tested compounds were found to be NE and 5-HT reuptake inhibitors except 14d which exhibited selective 5-HT reuptake inhibition activity.


Asunto(s)
Proteínas de Transporte de Noradrenalina a través de la Membrana Plasmática/metabolismo , Norepinefrina/farmacología , Inhibidores Selectivos de la Recaptación de Serotonina/síntesis química , Proteínas de Transporte de Serotonina en la Membrana Plasmática/metabolismo , Serotonina/farmacología , Tropanos/síntesis química , 5-Hidroxitriptófano/toxicidad , Antagonistas Adrenérgicos alfa/toxicidad , Animales , Citalopram/síntesis química , Citalopram/química , Clomipramina/síntesis química , Clomipramina/química , Cristalografía por Rayos X , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Fluoxetina/síntesis química , Fluoxetina/química , Ratones , Estructura Molecular , Proteínas de Transporte de Noradrenalina a través de la Membrana Plasmática/efectos de los fármacos , Proteínas de Transporte de Serotonina en la Membrana Plasmática/efectos de los fármacos , Inhibidores Selectivos de la Recaptación de Serotonina/farmacología , Tropanos/química , Tropanos/farmacología , Yohimbina/antagonistas & inhibidores , Yohimbina/toxicidad
18.
Electrophoresis ; 28(20): 3650-7, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17893949

RESUMEN

CE of tricyclic antidepressants clomipramine and its metabolites demethylclomipramine, didemethylclomipramine and 8-hydroxyclomipramine resulted in partly extremely tailing peaks in bare fused-silica capillaries. Especially at high pH of the BGE this behavior was not unexpected as adsorption of the cationic analytes onto the negatively charged wall due to electrostatic attraction can be supposed. Less expected was the observation that peak tailing could not be overcome neither by using a capillary with dynamic coating with cationic CTAB added to the BGE, nor by the usage of a capillary permanently coated with polyvinyl alcohol (PVA), both operated at acidic pH. As this tailing was even more pronounced than with bare fused silica, and was suppressed upon addition of MeCN to the BGE, another source of adsorption than pure ion-ion interaction seems plausible. In the bare silica capillary the mobility, mu, of the analytes followed roughly the pH dependence of a monoacidic base, but two deviations from the sigmoid theoretical curve were evident: (i) even at low pH the mobilities were not constant; they decreased in contrary with pH over the entire range; (ii) the apparent pK(a) values of two analytes, derived at the pH with halve the mobility at low pH, are significantly smaller than the thermodynamic pK(a). Upon modifying the expression for mu = f(pH), and considering the pH dependence of the negative charge density at the wall by an additional term which takes chromatographic retention into account, an equation was derived which enables the description of the observed electromigration of the analytes as function of pH, pK(a) of analytes and surface silanol groups, actual mobility of analytes, distribution coefficient (or retention factor) due to adsorption including its pH dependence. The interplay of electrophoretic movement and residual adsorptive retention allowed to resolve the analytes finally in an uncoated capillary, namely at pH 7.65 (30 mM ionic strength), whereas at the cost of the robustness of the separation system.


Asunto(s)
Antidepresivos Tricíclicos/química , Antidepresivos Tricíclicos/aislamiento & purificación , Clomipramina/química , Clomipramina/aislamiento & purificación , Electroforesis Capilar/métodos , Bromuro de Hexadimetrina/química , Adsorción/efectos de los fármacos , Algoritmos , Tampones (Química) , Cationes , Técnicas de Química Analítica/métodos , Clomipramina/análogos & derivados , Electroforesis Capilar/instrumentación , Bromuro de Hexadimetrina/metabolismo , Concentración de Iones de Hidrógeno , Sensibilidad y Especificidad , Dióxido de Silicio/química , Espectrofotometría Ultravioleta
19.
Pharmazie ; 57(6): 405-8, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12116878

RESUMEN

The isolation and identification of the photodegradation products of clomipramine (CIP) in phosphate buffered saline (PBS pH 7.4 and 6.0) solution and methanol under aerobic conditions were studied. Six compounds were identified and four of them were isolated and characterized by spectroscopic methods. A radical mechanism with the participation of the solvent is proposed for the photodegradation of CIP which undergoes homolytic cleavage of the carbon-chlorine bond and also photooxidation of the amine group. CIP was able to induce photohemolysis when it was irradiated in PBS pH 7.4 and in PBS pH 6.0 containing a suspension of human red blood cells (RBCs). The photohemolysis experiments in the presence of additives DABCO and GSH showed nearly total inhibition of drug-induced photohemolysis. The efficient inhibition of photohemolysis by the radical scavenger GSH compared with the inhibition show by DABCO suggests a moderate effect by singlet oxygen. Clomipramine-N-oxide was the unique photoproduct able to induce hemolysis and photohemolysis when it was incubated and irradiated with RBCs for 1 h. A mechanism involving singlet oxygen, radicals and photoproducts is suggested for the reported phototoxicity.


Asunto(s)
Antidepresivos Tricíclicos/química , Clomipramina/química , Dermatitis Fototóxica/sangre , Eritrocitos/efectos de los fármacos , Aerobiosis , Antidepresivos Tricíclicos/efectos de la radiación , Clomipramina/efectos de la radiación , Hemólisis/efectos de los fármacos , Hemólisis/efectos de la radiación , Humanos , Concentración de Iones de Hidrógeno , Técnicas In Vitro , Fotoquímica , Fotólisis , Rayos Ultravioleta
20.
Eur J Med Chem ; 36(6): 539-43, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11525844

RESUMEN

Ten new 3,5-diphenyl-2-pyrazoline derivatives were synthesised by reacting 1,3-diphenyl-2-propen-1-one with hydrazine hydrate. The chemical structures of the compounds were proved by means of their IR, 1H-NMR spectroscopic data and microanalyses. The antidepressant activities of these compounds were evaluated by the 'Porsolt Behavioural Despair Test' on Swiss-Webster mice. 3-(4-Methoxyphenyl)-5-(3,4-dimethoxyphenyl)-2-pyrazoline, 3-(4-methoxyphenyl)-5-(2-chloro-3,4-dimethoxyphenyl)-2-pyrazoline and 3-(4-chlorophenyl)-5-(2-chloro-3,4-dimethoxyphenyl)-2-pyrazoline reduced 41.94-48.62% immobility times at 100 mgkg(-1) dose level. In addition, it was found that 4-methoxy and 4-chloro substituents on the phenyl ring at position 3 of the pyrazoline ring increased the antidepressant activity; the replacement of these groups by bromo and methyl substituents decreased activity in mice.


Asunto(s)
Antidepresivos/síntesis química , Antidepresivos/farmacología , Pirazoles/síntesis química , Pirazoles/farmacología , Animales , Clomipramina/síntesis química , Clomipramina/química , Clomipramina/farmacología , Relación Dosis-Respuesta a Droga , Diseño de Fármacos , Evaluación Preclínica de Medicamentos , Espectroscopía de Resonancia Magnética , Masculino , Ratones , Pruebas Neuropsicológicas , Pirazoles/química , Espectrofotometría Infrarroja , Relación Estructura-Actividad , Natación , Tranilcipromina/síntesis química , Tranilcipromina/química , Tranilcipromina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...